Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial

导出原文传递

翻译打印收藏纠错

作者： Ross, S. A. ^[1] ; Caballero, A. E. ^[2] ; Del Prato, S. ^[3] ; Gallwitz, B. ^[4] ; Lewis-D'Agostino, D. ^[5] ; Bailes, Z. ^[6] ; Thiemann, S. ^[7] ; Patel, S. ; Woerle, H. -J. ; von Eynatten, M.

作者单位： Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA ^[1] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA ^[2] Univ Klinikum Tubingen, Dept Med 4, Tubingen, Germany ^[3] Boehringer Ingelheim Ltd, Bracknell, Berks, England ^[4] Univ Calgary, LMC Endocrinol Ctr, Calgary, AB T2H 2G4, Canada ^[5] Univ Pisa, Sect Diabet, Dept Endocrinol & Metab, Pisa, Italy ^[6] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany ^[7]

关键词 antidiabetes drug clinical trial metformin DPP-4 inhibitor type 2 diabetes

发布时间 2015-10-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交